Weed (BUDZ) Shares Outstanding (Diluted Average) (2010 - 2026)
Weed (BUDZ) recorded quarterly Shares Outstanding (Diluted Average) of $147.5 million in Q1 2026, up 8.53% quarter-over-quarter from $135.9 million in Q4 2025, and up 11.39% on a YoY basis from $132.4 million in Q1 2025.
Weed (BUDZ) Shares Outstanding (Diluted Average) (2010 - 2026) Analysis & Trends
Weed's Shares Outstanding (Diluted Average) history runs 7 years deep, the most recent figure standing at $147.5 million for Q1 2026.
- In Q1 2026, Shares Outstanding (Diluted Average) rose 11.39% year-over-year to $147.5 million; the TTM figure through Mar 2026 stood at $147.5 million (up 11.39% YoY), while the FY2025 annual figure was $135.9 million, up 9.5% from the prior year.
- Shares Outstanding (Diluted Average) was $147.5 million for Q1 2026 at Weed, up from $135.9 million in the prior quarter.
- In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $147.5 million in Q1 2026 to a low of $123.7 million in Q4 2023.
- Historically, Shares Outstanding (Diluted Average) has averaged $130.9 million across 4 years, with a median of $129.1 million in 2024.
- The sharpest annual moves came in 2024 and 2026: Shares Outstanding (Diluted Average) increased 0.34% in 2024, then climbed 11.39% in 2026.
- A 4-year view of Shares Outstanding (Diluted Average) shows it stood at $123.7 million in 2023, then advanced by 0.34% to $124.1 million in 2024, then climbed by 9.5% to $135.9 million in 2025, then gained by 8.53% to $147.5 million in 2026.
- The last three Shares Outstanding (Diluted Average) figures came in at $147.5 million (Q1 2026), $135.9 million (Q4 2025), and $134.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 1.18 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 422.40 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 47.20 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 103.40 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 506.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 228.36 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | - |
| 10 | Weed | - | - | - | 147.51 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 147.51 Mn |
| Dec 31, 2025 | 135.92 Mn |
| Sep 30, 2025 | 134.78 Mn |
| Jun 30, 2025 | 135.93 Mn |
| Mar 31, 2025 | 132.43 Mn |
| Dec 31, 2024 | 124.13 Mn |
| Sep 30, 2024 | 125.68 Mn |
| Jun 30, 2024 | 125.18 Mn |
| Mar 31, 2024 | 123.81 Mn |
| Dec 31, 2023 | 123.71 Mn |
| Mar 31, 2012 | 13.74 Mn |
| Dec 31, 2011 | 12.13 Mn |
| Sep 30, 2011 | 11.77 Mn |
| Jun 30, 2011 | 11.74 Mn |
| Mar 31, 2011 | 11.67 Mn |
| Dec 31, 2010 | 11.26 Mn |
| Sep 30, 2010 | 11.34 Mn |
| Jun 30, 2010 | 11.07 Mn |